SGS North America Announces Expansion of Biologics Testing Capabilities
SGS North America (SGS) announced today that it has added new capacity and capabilities to bolster its biologics testing services…
Tag: biopharmaceuticals
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects
The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK)…
Rockland Launches Impurity Detection Kit for Accurate Measurement of Nuclease Across a Spectrum of Therapeutic Manufacturing Methods
For over 60 years, Rockland has been providing antibodies, assays, and supporting reagents to accurately reflect the quality of biopharmaceutical products from…
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates
WuXi Biologics (“WuXi Bio”) (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that its…
Haystack Oncology and Rutgers Cancer Institute Collaborate to use Haystack MRD™ in Clinical Study of Early-Stage Triple-Negative Breast Cancer
Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, has entered into a collaboration with Rutgers Cancer Institute of New Jersey to use Haystack…
Vaccine Partner Valneva receives FDA approval for the World’s first chikungunya vaccine using Albumedix’ Recombumin®
The FDA on 10th November 2023 announced the approval of IXCHIQ®, Valneva’s vaccine against the chikungunya virus. Notably, this is the first vaccine…
Trio Health Appoints Dr. Mia Nease as Chief Commercial Officer
Trio Health (Trio), a leading clinical data solution provider, has announced the appointment of Mia Nease as its Chief Commercial Officer (CCO).…
Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
Chime Biologics, a leading CDMO that enables its partners’ success in biologics, and Hope Medicine Inc. (HopeMed), a science-driven, patient-centric, clinical-stage…
Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM
Veeva Systems (NYSE: VEEV) today announced that 17 of the top 20 biopharmas in Asia Pacific are using Veeva CRM…